HDAC9 and NFATC1, which were characteristically expressed in the neuroendocrine group in adult TECs and thymic carcinomas, should be investigated further due to their potential biological significance in TECs and their possibility of being therapeutic targets of thymic carcinomas. This evidence concerns the gene NFATC1 and thymic carcinoma.